EPIX - Income Statement - ESSA Pharma Inc.

	Sep-2024	Sep-2023	Sep-2022	Sep-2021	Sep-2020	Sep-2019	Sep-2018	Sep-2017	Sep-2016	Sep-2015	Sep-2014	Sep-2013	Dec-2012
REVENUE
Revenue	0	0	0	0	0	0	0	0	217	0	0	0	0
GROSS PROFIT
Cost Of Revenue	0	0.1	0.1	0.1	0.1	0	34.5 K	46.1 K	66.2 K	0	0	0	0
Gross Profit	0	(0.1)	(0.1)	(0.1)	(0.1)	0	34.5 K	46.1 K	66 K	0	0	0	0
OPERATING INCOME
Operating Expenses	21.2	32.1	37.0	37.1	23.5	12.2	10.8	10.9	18.7	9.2	1.7	1.4	1.94 K
Selling, General and Administrative Expenses	0	10.8	12.5	12.8	11.4	5.5	5.9	5.1	5.6	3.7	1.0	0.4	298
Research and Development Expenses	21.2	21.3	24.4	24.3	12.1	6.7	4.9	5.7	13.1	4.4	0.7	1.6	1.76 K
Operating Income	0	(32.1)	(35.3)	(36.9)	(23.1)	(12.2)	(10.8)	(11.7)	(19.6)	(9.3)	(1.8)	(1.4)	1.94 K
PRE-TAX INCOME
Interest Income Expense	0	6.94 K	14 K	22.2 K	0.6	0.6	0.9	0.8	0.9	77.8 K	87.6 K	0	0
Total Other Income	0	5.6	1.7	0.3	(0.2)	(0.6)	(0.6)	11.7	5.7	(0.1)	608	0.6	1.42
Pre-Tax Income	0	(26.6)	(35.2)	(36.8)	(23.7)	(10.4)	(11.6)	(4.4)	(13.0)	(8.6)	(1.8)	(1.4)	1.94 K
NET INCOME
Tax Provision	0	1.6 K	(0.1)	34.3 K	(0.3)	38 K	27 K	0.1	0.2	77.8 K	87.6 K	0.28	0
Net Income	0	(26.6)	(35.1)	(36.8)	(23.4)	(10.4)	(11.6)	(4.5)	(13.1)	(8.6)	(1.8)	(1.4)	1.94 K
EPS	0.64	0.6	0.8	0.96	1.04	1.24	2.55	3.09	9.77	9.34	2.33	1.75	2.65

Free